The vision for EPAG is that the group will remain the principal industry-based opinion leading and influencing group for the pharmaceutical development and regulation of products for pulmonary and nasal delivery in Europe.
EPAG will continue to be recognised internationally as a valued contributor to the world-wide pulmonary and nasal product development and regulation arena.